|
CN110917342A
|
|
Immunomodulatory compositions and uses thereof
|
|
CN110904133A
|
|
Composition for synergistically relieving T cell failure and application
|
|
CN110743006A
|
|
Composition for synergistically relieving immune cell failure and application
|
|
CN110777115A
|
|
Composition for enhancing capacity of antigen presenting cells to sensitize T cells and application
|
|
CN110732021A
|
|
Composition for relieving tumor immunosuppression and application thereof
|
|
CN111166876A
|
|
Immunopotentiator combination, coding nucleic acid and application thereof
|
|
CN111166895A
|
|
Immune microenvironment regulator combination, coding nucleic acid and application thereof
|
|
CN107674915A
|
|
A kind of application of circular rna in colorectal cancer biomarker
|
|
CN107674916A
|
|
A kind of application of circular rna in colorectal cancer biomarker
|
|
CN107604062A
|
|
A kind of more antigen detection methods for liver cancer immunity treatment
|
|
CN107929727A
|
|
A kind of preparation method of new dendritic cell vaccine
|
|
CN107385062A
|
|
Applications of the YKL 40 as glioblastoma biomarker
|
|
CN107583042A
|
|
A kind of general hepatic carcinoma antigen composition and its production and use
|
|
CN107793484A
|
|
A kind of recombinant tumor antigen its preparation method and code nucleic acid and its application
|
